IL50816A - 6-aryl-s-triazolo(4,3-a)-(or tetrazolo(1,5-a)pyrido(2,3-f)-diazepines, their preparation and pharmaceutical compositions containing them - Google Patents

6-aryl-s-triazolo(4,3-a)-(or tetrazolo(1,5-a)pyrido(2,3-f)-diazepines, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL50816A
IL50816A IL50816A IL5081676A IL50816A IL 50816 A IL50816 A IL 50816A IL 50816 A IL50816 A IL 50816A IL 5081676 A IL5081676 A IL 5081676A IL 50816 A IL50816 A IL 50816A
Authority
IL
Israel
Prior art keywords
diazepines
tetrazolo
triazolo
pyrido
aryl
Prior art date
Application number
IL50816A
Other languages
English (en)
Other versions
IL50816A0 (en
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of IL50816A0 publication Critical patent/IL50816A0/xx
Publication of IL50816A publication Critical patent/IL50816A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL50816A 1975-11-04 1976-11-02 6-aryl-s-triazolo(4,3-a)-(or tetrazolo(1,5-a)pyrido(2,3-f)-diazepines, their preparation and pharmaceutical compositions containing them IL50816A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT837275A AT350056B (de) 1975-11-04 1975-11-04 Verfahren zur herstellung von neuen pyrido- (2,3-f)-(1,4)-diazepinen, deren optischen isomeren und salzen

Publications (2)

Publication Number Publication Date
IL50816A0 IL50816A0 (en) 1977-01-31
IL50816A true IL50816A (en) 1980-09-16

Family

ID=3604891

Family Applications (1)

Application Number Title Priority Date Filing Date
IL50816A IL50816A (en) 1975-11-04 1976-11-02 6-aryl-s-triazolo(4,3-a)-(or tetrazolo(1,5-a)pyrido(2,3-f)-diazepines, their preparation and pharmaceutical compositions containing them

Country Status (30)

Country Link
US (1) US4110455A (fi)
JP (1) JPS5831351B2 (fi)
AR (3) AR217814A1 (fi)
AT (1) AT350056B (fi)
AU (1) AU504228B2 (fi)
BE (1) BE847952A (fi)
CA (1) CA1076111A (fi)
CH (1) CH630920A5 (fi)
CS (1) CS191181B2 (fi)
DD (1) DD128178A5 (fi)
DE (1) DE2649116A1 (fi)
DK (1) DK142324B (fi)
EG (1) EG12280A (fi)
ES (2) ES452971A1 (fi)
FI (1) FI62088C (fi)
FR (1) FR2330404A1 (fi)
GB (1) GB1562800A (fi)
HU (1) HU177422B (fi)
IL (1) IL50816A (fi)
IN (1) IN144289B (fi)
MX (1) MX4284E (fi)
NL (1) NL7612187A (fi)
NO (1) NO146470C (fi)
PL (2) PL118308B1 (fi)
PT (1) PT65787B (fi)
RO (2) RO77294A (fi)
SE (1) SE7612260L (fi)
SU (2) SU667137A3 (fi)
YU (1) YU269176A (fi)
ZA (1) ZA766620B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1185601A (en) * 1981-02-27 1985-04-16 Walter Hunkeler Imidazodiazepines
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
US8541407B2 (en) 2010-03-31 2013-09-24 Arqule, Inc. Substituted benzo-pyrido-triazolo-diazepine compounds
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2705039B1 (en) 2011-05-04 2017-07-26 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2721031B1 (en) 2011-06-17 2016-01-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2013184878A1 (en) 2012-06-06 2013-12-12 Constellation Pharmaceuticals, Inc. Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
DK3157928T3 (da) 2014-06-20 2019-05-20 Constellation Pharmaceuticals Inc Krystallinske former af 2-((4s)-6-(4-chlorphenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT327917B (de) * 1973-04-12 1976-02-25 Degussa Verfahren zur herstellung von neuen 5-aryl-pyrido- (b-6,7) -1,4-diazepinen und deren salzen
US4039551A (en) * 1976-03-15 1977-08-02 The Upjohn Company 1-[(Hydroxyamino)methyl]-6-aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines

Also Published As

Publication number Publication date
PL113803B1 (en) 1981-01-31
NO763739L (fi) 1977-05-05
JPS5259194A (en) 1977-05-16
ATA837275A (de) 1978-10-15
RO70245A (ro) 1981-06-30
AR216915A1 (es) 1980-02-15
CH630920A5 (de) 1982-07-15
RO77294A (ro) 1982-09-09
BE847952A (fr) 1977-05-03
IL50816A0 (en) 1977-01-31
ES452971A1 (es) 1978-10-16
NO146470B (no) 1982-06-28
PL193439A1 (pl) 1979-07-16
AR217814A1 (es) 1980-04-30
FR2330404B1 (fi) 1979-07-20
FI763158A (fi) 1977-05-05
IN144289B (fi) 1978-04-22
AU1931176A (en) 1978-05-11
YU269176A (en) 1983-02-28
DK142324B (da) 1980-10-13
SU676165A3 (ru) 1979-07-25
ES452969A1 (es) 1977-11-16
DE2649116A1 (de) 1977-05-18
FR2330404A1 (fr) 1977-06-03
FI62088C (fi) 1982-11-10
AT350056B (de) 1979-05-10
NO146470C (no) 1982-10-06
PL118308B1 (en) 1981-09-30
DK497076A (fi) 1977-05-05
CA1076111A (en) 1980-04-22
DK142324C (fi) 1981-03-02
SE7612260L (sv) 1977-05-05
AU504228B2 (en) 1979-10-04
JPS5831351B2 (ja) 1983-07-05
US4110455A (en) 1978-08-29
FI62088B (fi) 1982-07-30
MX4284E (es) 1982-03-12
SU667137A3 (ru) 1979-06-05
PT65787B (de) 1978-05-10
PT65787A (de) 1976-12-01
HU177422B (en) 1981-10-28
EG12280A (en) 1978-12-31
CS191181B2 (en) 1979-06-29
DD128178A5 (de) 1977-11-02
AR216916A1 (es) 1980-02-15
NL7612187A (nl) 1977-05-06
ZA766620B (en) 1977-12-28
GB1562800A (en) 1980-03-19

Similar Documents

Publication Publication Date Title
IL62494A0 (en) 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidin-4-one derivatives,their preparation and pharmaceutical compositions containing them
DE3166531D1 (en) Imidazo(1,2-a)pyridines, processes for their preparation and pharmaceutical compositions containing them
IL48423A (en) (4-acylpiperazin-1-yl)carbonyloxyisoindolinones,5h-pyrrolo(3,4-b)pyrazines, 5h-1,4-oxathiano(2,3-c) pyrroles, their preparation and pharmaceutical compositions containing thesame
PH12259A (en) Substituted imidazo(1,2-a)pyridines and composition containing them
IL87714A0 (en) 3,7-diazabicyclo(3,3,1)nonane derivatives,their preparation and pharmaceutical compositions containing them
IL56078A (en) 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido(1,2-a)-pyrimidin-4-one derivatives,their preparation and pharmaceutical compositions containing them
IL68442A0 (en) Imidazo(1,2-a)pyridine derivatives,their preparation and pharmaceutical compositions containing them
IL48069A (en) Imidazo-(1,5-a)(1,4)-diazepine derivatives, their preparation and pharmaceutical compositions containing them
IL55338A0 (en) Novel pyrido (1,2-a)pyrimidine derivatives, their preparation and pharmaceutical compositions containing them
IL52997A0 (en) New 1h-pyrazolo(3,4-b)pyridine derivatives their preparation and pharmaceutical compositions containing them
IL50816A (en) 6-aryl-s-triazolo(4,3-a)-(or tetrazolo(1,5-a)pyrido(2,3-f)-diazepines, their preparation and pharmaceutical compositions containing them
IL50208A0 (en) Triazolo (3,4-b) isoquinoline derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL50930A (en) 1-alkyl-4-oxo-1,6,7,8-tetrahydro-4h-pyrido(1,2-a)pyrimidine-3-carboxamide derivatives,their preparation and pharmaceutical compositions containing them
IL54813A0 (en) Novel pyrido(2,3-b) (1,4) benzodiazepine derivatives, their preparation and pharmaceutical compositions containing
IL70485A (en) Imidazo(1,5-a)pyridine derivatives,their preparation and pharmaceutical compositions containing them
IL54814A0 (en) Novel pyrido(2,3-b) (1,4) benzodiazepine derivatives, their preparation and pharmaceutical compositions containing tthem
IL44127A0 (en) Imidazo(4,5-b)pyridines,their preparation and pharmaceutical compositions containing them
IL59802A0 (en) Substituted pyrido (1,2-a) pyrimidines,their preparation and pharmaceutical compositions containing them
IL52857A0 (en) Novel benzopyrane derivatives their preparation and pharmaceutical compositions containing them
IL51853A (en) 1,2,3,3a-tetrahydro(or 1,2,3,3a,4,5-hexahydro)indolo(3,2,1-de)naphthyridine derivatives,their preparation and pharmaceutical compositions containing them
IL62295A0 (en) Pyrazolopyridine derivatives,their preparation and pharmaceutical compositions containing them
IL49606A (en) Imidazo rifamycin derivatives and their preparation
IL46864A0 (en) New pyrimido(1,2-a)quinoline derivatives,their preparation and pharmaceutical compositions containing them
IL44895A (en) 3h-thiazolo(4,3-a)isoquinolines and 2h-isohtiazolo(3,2-a)isoquinolines their preparation and pharmaceutical compositions containing them
IL49614A (en) 4,5-dihydrotetrazolo(1,5-a)quinoxalines,their preparation and agrilultural antimicrobial compositions containing them